NZ511882A - Preparation containing a nucleotide synthesis inhibitor and antagonist of the nucleotide synthesis inhibitor - Google Patents
Preparation containing a nucleotide synthesis inhibitor and antagonist of the nucleotide synthesis inhibitorInfo
- Publication number
- NZ511882A NZ511882A NZ511882A NZ51188299A NZ511882A NZ 511882 A NZ511882 A NZ 511882A NZ 511882 A NZ511882 A NZ 511882A NZ 51188299 A NZ51188299 A NZ 51188299A NZ 511882 A NZ511882 A NZ 511882A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- group
- disorders
- nucleotide synthesis
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19857009A DE19857009A1 (de) | 1998-12-10 | 1998-12-10 | Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren |
| PCT/EP1999/009380 WO2000033876A1 (de) | 1998-12-10 | 1999-12-01 | Zubereitung mit verbesserter therapeutischer breite, enthaltend nukleotidsyntheseinhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ511882A true NZ511882A (en) | 2003-11-28 |
Family
ID=7890633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ511882A NZ511882A (en) | 1998-12-10 | 1999-12-01 | Preparation containing a nucleotide synthesis inhibitor and antagonist of the nucleotide synthesis inhibitor |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1137438B1 (de) |
| JP (1) | JP2002531525A (de) |
| KR (1) | KR20010080729A (de) |
| CN (1) | CN1189214C (de) |
| AR (1) | AR021577A1 (de) |
| AT (1) | ATE218370T1 (de) |
| AU (1) | AU766810B2 (de) |
| BG (1) | BG105548A (de) |
| BR (1) | BR9916006A (de) |
| CA (1) | CA2354266A1 (de) |
| CZ (1) | CZ20012029A3 (de) |
| DE (2) | DE19857009A1 (de) |
| DK (1) | DK1137438T3 (de) |
| EA (1) | EA005136B1 (de) |
| EE (1) | EE200100305A (de) |
| ES (1) | ES2178496T3 (de) |
| HK (1) | HK1041598B (de) |
| HR (1) | HRP20010429A2 (de) |
| HU (1) | HUP0104624A3 (de) |
| IL (1) | IL143586A0 (de) |
| MX (1) | MXPA01005861A (de) |
| NO (1) | NO20012719D0 (de) |
| NZ (1) | NZ511882A (de) |
| PL (1) | PL349336A1 (de) |
| PT (1) | PT1137438E (de) |
| SI (1) | SI1137438T1 (de) |
| SK (1) | SK284842B6 (de) |
| WO (1) | WO2000033876A1 (de) |
| YU (1) | YU39901A (de) |
| ZA (1) | ZA200104815B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10112924A1 (de) * | 2001-03-13 | 2002-10-02 | Erich Eigenbrodt | 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate |
| JP4382354B2 (ja) * | 2001-03-13 | 2009-12-09 | ヴァルブルク・グリコムド・ゲーエムベーハー | １−ブタン酸誘導体およびその使用 |
| GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| US20040127435A1 (en) * | 2002-08-02 | 2004-07-01 | Regents Of The University Of California | Uses for inhibitors of inosine monophosphate dehydrogenase |
| AU2003258454A1 (en) | 2002-09-06 | 2004-04-30 | Schebo®Biotech Ag | Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| JPWO2005060980A1 (ja) * | 2003-12-24 | 2007-12-13 | 正彬 少名子 | 疾患治療用医薬及び糖尿病治療用医薬 |
| DE102005017592A1 (de) * | 2005-04-16 | 2006-10-19 | Lindner, Jürgen, Dr. med. | Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem |
| JP4657384B2 (ja) | 2007-05-03 | 2011-03-23 | ファイザー・リミテッド | ナトリウムチャンネルモジュレーターとしての２−ピリジンカルボキサミド誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4127737A1 (de) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
| EP0538783B1 (de) * | 1991-10-23 | 1995-09-27 | Hoechst Aktiengesellschaft | N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft |
| IT1254519B (it) * | 1992-03-16 | 1995-09-25 | Chiesi Farma Spa | Associazioni di composti ad attivita' antivirale |
| DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
| AU4596097A (en) * | 1996-09-26 | 1998-04-17 | Williams, James W. | Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives |
-
1998
- 1998-12-10 DE DE19857009A patent/DE19857009A1/de not_active Withdrawn
-
1999
- 1999-12-01 CA CA002354266A patent/CA2354266A1/en not_active Abandoned
- 1999-12-01 PT PT99961041T patent/PT1137438E/pt unknown
- 1999-12-01 WO PCT/EP1999/009380 patent/WO2000033876A1/de not_active Application Discontinuation
- 1999-12-01 EP EP99961041A patent/EP1137438B1/de not_active Expired - Lifetime
- 1999-12-01 EA EA200100647A patent/EA005136B1/ru not_active IP Right Cessation
- 1999-12-01 DK DK99961041T patent/DK1137438T3/da active
- 1999-12-01 NZ NZ511882A patent/NZ511882A/en unknown
- 1999-12-01 ES ES99961041T patent/ES2178496T3/es not_active Expired - Lifetime
- 1999-12-01 KR KR1020017007176A patent/KR20010080729A/ko not_active Application Discontinuation
- 1999-12-01 MX MXPA01005861A patent/MXPA01005861A/es active IP Right Grant
- 1999-12-01 HU HU0104624A patent/HUP0104624A3/hu unknown
- 1999-12-01 AU AU17793/00A patent/AU766810B2/en not_active Ceased
- 1999-12-01 BR BR9916006-4A patent/BR9916006A/pt not_active IP Right Cessation
- 1999-12-01 AT AT99961041T patent/ATE218370T1/de not_active IP Right Cessation
- 1999-12-01 DE DE59901681T patent/DE59901681D1/de not_active Expired - Fee Related
- 1999-12-01 JP JP2000586366A patent/JP2002531525A/ja not_active Withdrawn
- 1999-12-01 CZ CZ20012029A patent/CZ20012029A3/cs unknown
- 1999-12-01 EE EEP200100305A patent/EE200100305A/xx unknown
- 1999-12-01 PL PL99349336A patent/PL349336A1/xx not_active Application Discontinuation
- 1999-12-01 IL IL14358699A patent/IL143586A0/xx unknown
- 1999-12-01 SK SK788-2001A patent/SK284842B6/sk unknown
- 1999-12-01 SI SI9930063T patent/SI1137438T1/xx unknown
- 1999-12-01 YU YU39901A patent/YU39901A/sh unknown
- 1999-12-01 CN CNB998142433A patent/CN1189214C/zh not_active Expired - Fee Related
- 1999-12-07 AR ARP990106239A patent/AR021577A1/es not_active Application Discontinuation
-
2001
- 2001-05-30 BG BG105548A patent/BG105548A/xx unknown
- 2001-06-01 NO NO20012719A patent/NO20012719D0/no not_active Application Discontinuation
- 2001-06-07 HR HR20010429A patent/HRP20010429A2/hr not_active Application Discontinuation
- 2001-06-13 ZA ZA200104815A patent/ZA200104815B/en unknown
-
2002
- 2002-05-02 HK HK02103282.9A patent/HK1041598B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2198655C2 (ru) | Комбинированный препарат, содержащий 4-(трифторметил)анилид 5-метилизоксазол-4-карбоновой кислоты и n-(4-трифторметилфенил)амид 2-циано-3-гидроксикротоновой кислоты | |
| JP2008539250A (ja) | アテローム性動脈硬化症を処置するための方法 | |
| CA3038500A1 (en) | Method of treating urothelial carcinoma and other genitourinary malignancies using n-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | |
| NZ511882A (en) | Preparation containing a nucleotide synthesis inhibitor and antagonist of the nucleotide synthesis inhibitor | |
| EP0295836B1 (de) | Verwendung von Dioxopiperidin-Derivaten zur Herstellung eines topischen Präparates als Analgetika | |
| JPH0140009B2 (de) | ||
| WO1999055158A1 (en) | S-rabeprazole compositions and methods | |
| US20050255071A1 (en) | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors | |
| NZ188098A (en) | Antithrombotic compositions based on synergistic combinations of 2,6-bis-(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine and 1,2-diphenyl-4-(2-phenylsulphinylethyl)pyrazolidine-3,5-dione | |
| US4315934A (en) | Organic compounds | |
| JP2001510155A (ja) | 選択的セロトニン再摂取阻害剤を用いる心臓障害の治療および予防 | |
| EP1073332A1 (de) | R-rabeprazol enthaltende zusammensetzungen und verfahren | |
| NZ192924A (en) | Anti-hypertensive compositions containing endralazine, pendolol and a salidiuretic | |
| JPH04266825A (ja) | 睡眠障害の処置剤 | |
| US20090281194A1 (en) | Combinations for treating HIV-associated pain | |
| AU4281993A (en) | Compositions of platelet activating factor antagonists and methods of treating interleukin-2 induced lung injury therewith | |
| MXPA98007564A (en) | Preparation in combination containing 5-methyl-4'-trifluometil-4'-isoxazolcarboxanilide and n- (4-trifluorometilfenil) -2-cyano-3-hydroxicrotonam | |
| SI9400354A (sl) | Farmacevtski sestavki,ki vsebujejo azaspiranski derivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |